EP3122764 - CYCLIC APELIN ANALOGS [Right-click to bookmark this link] | Status | No opposition filed within time limit Status updated on 22.11.2019 Database last updated on 02.11.2024 | |
Former | The patent has been granted Status updated on 14.12.2018 | ||
Former | Grant of patent is intended Status updated on 09.10.2018 | ||
Former | Examination is in progress Status updated on 09.02.2018 | ||
Former | Request for examination was made Status updated on 30.12.2016 | ||
Former | The international publication has been made Status updated on 31.10.2016 | Most recent event Tooltip | 01.07.2022 | Lapse of the patent in a contracting state New state(s): MK | published on 03.08.2022 [2022/31] | Applicant(s) | For all designated states LanthioPep B.V. Rozenburglaan 13B 9727 DL Groningen / NL | [2017/05] | Inventor(s) | 01 /
RINK, Rick c/o Rozenburglaan 13B NL-9727 DL Groningen / NL | [2017/05] | Representative(s) | Spiller, Stephan MorphoSys AG Semmelweisstrasse 7 82152 Planegg / DE | [2019/03] |
Former [2017/05] | Spiller, Stephan MorphoSys AG Intellectual Property Lena-Christ-Strasse 48 82152 Martinsried/Planegg / DE | Application number, filing date | 15720489.2 | 25.03.2015 | [2017/05] | WO2015NL50191 | Priority number, date | EP20140161533 | 25.03.2014 Original published format: EP 14161533 | [2017/05] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2015147641 | Date: | 01.10.2015 | Language: | EN | [2015/39] | Type: | A1 Application with search report | No.: | EP3122764 | Date: | 01.02.2017 | Language: | EN | The application published by WIPO in one of the EPO official languages on 01.10.2015 takes the place of the publication of the European patent application. | [2017/05] | Type: | B1 Patent specification | No.: | EP3122764 | Date: | 16.01.2019 | Language: | EN | [2019/03] | Search report(s) | International search report - published on: | EP | 01.10.2015 | Classification | IPC: | C07K7/08, C07K14/47, C07K7/54 | [2017/05] | CPC: |
C07K7/08 (EP,KR,RU,US);
C07K14/47 (EP,CN,KR,RU,US);
C07K7/54 (KR,RU,US);
A61K38/10 (KR);
A61K38/12 (KR,RU);
A61K38/1709 (KR);
A61P25/00 (EP,RU);
A61P25/18 (EP);
A61P25/22 (EP);
A61P25/24 (EP);
A61P3/00 (EP,RU);
A61P7/00 (EP);
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2017/05] | Extension states | BA | Not yet paid | ME | Not yet paid | Validation states | MA | Not yet paid | Title | German: | CYCLISCHE APELINANALOGA | [2017/05] | English: | CYCLIC APELIN ANALOGS | [2017/05] | French: | ANALOGUES D'APELINE CYCLIQUE | [2018/43] |
Former [2017/05] | ANALOGUES CYCLIQUES DE L'APÉLINE | Entry into regional phase | 25.10.2016 | National basic fee paid | 25.10.2016 | Designation fee(s) paid | 25.10.2016 | Examination fee paid | Examination procedure | 25.10.2016 | Examination requested [2017/05] | 25.10.2016 | Date on which the examining division has become responsible | 18.05.2017 | Amendment by applicant (claims and/or description) | 19.05.2017 | Loss of particular rights, legal effect: Claims | 23.06.2017 | Despatch of communication of loss of particular rights: Claims {1} | 09.02.2018 | Despatch of a communication from the examining division (Time limit: M04) | 13.06.2018 | Reply to a communication from the examining division | 10.10.2018 | Communication of intention to grant the patent | 04.12.2018 | Fee for grant paid | 04.12.2018 | Fee for publishing/printing paid | 04.12.2018 | Receipt of the translation of the claim(s) | Opposition(s) | 17.10.2019 | No opposition filed within time limit [2019/52] | Fees paid | Renewal fee | 24.03.2017 | Renewal fee patent year 03 | 23.03.2018 | Renewal fee patent year 04 |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Lapses during opposition Tooltip | AL | 16.01.2019 | CY | 16.01.2019 | EE | 16.01.2019 | LT | 16.01.2019 | LV | 16.01.2019 | MK | 16.01.2019 | RO | 16.01.2019 | RS | 16.01.2019 | SI | 16.01.2019 | SK | 16.01.2019 | SM | 16.01.2019 | TR | 16.01.2019 | MT | 25.03.2019 | BG | 16.04.2019 | IS | 16.05.2019 | [2022/31] |
Former [2021/26] | AL | 16.01.2019 | |
CY | 16.01.2019 | ||
EE | 16.01.2019 | ||
LT | 16.01.2019 | ||
LV | 16.01.2019 | ||
RO | 16.01.2019 | ||
RS | 16.01.2019 | ||
SI | 16.01.2019 | ||
SK | 16.01.2019 | ||
SM | 16.01.2019 | ||
TR | 16.01.2019 | ||
MT | 25.03.2019 | ||
BG | 16.04.2019 | ||
IS | 16.05.2019 | ||
Former [2020/29] | AL | 16.01.2019 | |
EE | 16.01.2019 | ||
LT | 16.01.2019 | ||
LV | 16.01.2019 | ||
RO | 16.01.2019 | ||
RS | 16.01.2019 | ||
SI | 16.01.2019 | ||
SK | 16.01.2019 | ||
SM | 16.01.2019 | ||
TR | 16.01.2019 | ||
MT | 25.03.2019 | ||
BG | 16.04.2019 | ||
IS | 16.05.2019 | ||
Former [2020/17] | AL | 16.01.2019 | |
EE | 16.01.2019 | ||
LT | 16.01.2019 | ||
LV | 16.01.2019 | ||
RO | 16.01.2019 | ||
RS | 16.01.2019 | ||
SI | 16.01.2019 | ||
SK | 16.01.2019 | ||
SM | 16.01.2019 | ||
TR | 16.01.2019 | ||
BG | 16.04.2019 | ||
IS | 16.05.2019 | ||
Former [2020/13] | AL | 16.01.2019 | |
EE | 16.01.2019 | ||
LT | 16.01.2019 | ||
LV | 16.01.2019 | ||
RO | 16.01.2019 | ||
RS | 16.01.2019 | ||
SI | 16.01.2019 | ||
SK | 16.01.2019 | ||
SM | 16.01.2019 | ||
BG | 16.04.2019 | ||
IS | 16.05.2019 | ||
Former [2019/51] | AL | 16.01.2019 | |
EE | 16.01.2019 | ||
LT | 16.01.2019 | ||
LV | 16.01.2019 | ||
RO | 16.01.2019 | ||
RS | 16.01.2019 | ||
SK | 16.01.2019 | ||
SM | 16.01.2019 | ||
BG | 16.04.2019 | ||
IS | 16.05.2019 | ||
Former [2019/49] | AL | 16.01.2019 | |
EE | 16.01.2019 | ||
LT | 16.01.2019 | ||
LV | 16.01.2019 | ||
RO | 16.01.2019 | ||
RS | 16.01.2019 | ||
SK | 16.01.2019 | ||
BG | 16.04.2019 | ||
IS | 16.05.2019 | ||
Former [2019/39] | LT | 16.01.2019 | |
LV | 16.01.2019 | ||
RS | 16.01.2019 | ||
BG | 16.04.2019 | ||
IS | 16.05.2019 | ||
Former [2019/38] | LT | 16.01.2019 | |
BG | 16.04.2019 | ||
Former [2019/33] | LT | 16.01.2019 | Cited in | International search | [Y]EP2405008 (LANTHIOPEP BV [NL]) [Y] 1-18 * paragraph [0014]; examples 1-5 *; | [Y]US2013196899 (ZECRI FREDERIC [US], et al) [Y] 1-14,18 * table 4 *; | [Y] - BOSMA TJIBBE ET AL, "Bacterial Display and Screening of Posttranslationally Thioether-Stabilized Peptides", APPLIED AND ENVIRONMENTAL MICROBIOLOGY, AMERICAN SOCIETY FOR MICROBIOLOGY, US, (20111001), vol. 77, no. 19, ISSN 0099-2240, pages 6794 - 6801, XP009153580 [Y] 1-18 * the whole document * | [Y] - JURI HAMADA ET AL, "Evaluation of novel cyclic analogues of apelin.", INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, (20081001), vol. 22, no. 4, ISSN 1107-3756, pages 547 - 552, XP055072884 [Y] 1-14,18 * the whole document * | by applicant | WO2012125408 | WO2013111110 | US2013196899 | - O'CARROLL ET AL., J. OF ENDOCRINOLOGY, (2013), vol. 219, pages R13 - R35 | - LEE ET AL., BIOCHEM BIOPHYS RES COMMUN., (2010), vol. 395, pages 185 - 189 | - MA; PEI, J. CELL SCIENCE, (2007), vol. 120, pages 213 - 218 | - ZHOU, N ET AL., APJ. VIROLOGY, (2003), vol. 307, pages 22 - 36 | - LEE, D. K.; GEORGE, S. R.; O'DOWD, B. F., TRENDS IN PHARMACOLOGICAL SCIENCES, (2006), vol. 27, pages 190 - 194 | - HAMADA, J., INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, (2008), vol. 22, pages 547 - 552 | - HAMADA ET AL., INT. J. OF MOL. MED., (2008), vol. 22, pages 547 - 552 | - ARNISON ET AL., NAT PROD REP, (2013), vol. 30, pages 108 - 160 | - MCAULIFFE ET AL., FEMS MICROBIOL. REV., (2001), vol. 25, pages 285 - 308 | - RINK ET AL., JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS, (2010), vol. 61, pages 210 - 218 | - BURRAGE ET AL., "Biomimetic synthesis of lantibiotics", CHEM EUR J, (2000), vol. 6, doi:doi:10.1002/(SICI)1521-3765(20000417)6:8<1455::AID-CHEM1455>3.0.CO;2-M, pages 1455 - 1466, XP008062604 DOI: http://dx.doi.org/10.1002/(SICI)1521-3765(20000417)6:8<1455::AID-CHEM1455>3.0.CO;2-M | - ZHU ET AL., "Biomimetic studies on the stereoselective lanthionine formation", ORG. BIOMOL. CHEM., (2003), vol. 1, pages 3304 - 3315 | - KNERR ET AL., J. AM. CHEM. SOC., (2012), vol. 134, no. 18, pages 7648 - 7651 | - ZHANG, PLOS, (2013), vol. 8, pages 1 - 11 | - SORLI, DRUG DISCOVERY TODAY, (2006), vol. 11, pages 1100 - 1106 | - KLUSKENS, L.D. ET AL., "Post-translational Modification of Therapeutic Peptides by NisB, the Dehydratase of the Lantibiotic Nisin", BIOCHEMISTRY, (2005), vol. 44, doi:doi:10.1021/bi050805p, pages 12827 - 12834, XP002424516 DOI: http://dx.doi.org/10.1021/bi050805p | - KLUSKENS, L.D. ET AL., "Angiotensin-(l-7) with thioether-bridge: an ACE-resistant, potent Ang-(1-7) analogue", J. PHARMACOL. EXPER. THER., (2009), vol. 328, pages 849 - 854 | - RINK, R. ET AL., "NisC, the cyclase of the lantibiotic nisin, can catalyze cyclization of designed non-lantibiotic peptides", BIOCHEMISTRY, (2007), vol. 46, doi:doi:10.1021/BI700106Z, pages 13179 - 13189, XP002546787 DOI: http://dx.doi.org/10.1021/BI700106Z | - KLUSKENS LD ET AL., "Post-translational modification of therapeutic peptides by NisB, the dehydratase of the lantibiotic nisin", BIOCHEMISTRY, (2005), vol. 44, doi:doi:10.1021/bi050805p, pages 12827 - 12834, XP002424516 DOI: http://dx.doi.org/10.1021/bi050805p | - RINK R ET AL., "Lantibiotic structures as guidelines for the design of peptides that can be modified by lantibiotic enzymes", BIOCHEMISTRY, (2005), vol. 44, doi:doi:10.1021/bi050081h, pages 8873 - 8882, XP002470472 DOI: http://dx.doi.org/10.1021/bi050081h | - RINK, BIOCHEMISTRY, (2007), vol. 46, pages 13179 - 13189 |